Denali Therapeutics Inc. (DNLI)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

10 annual periodsNewest to oldest
2025202420232022202120202019201820172016
Revenue$0$0$330.5M$105.1M$48.7M$335.6M$26.3M$129.1M$0$0
Research & development$418.8M$396.4M$423.9M$358.7M$265.4M$212.6M$193.4M$143.2M$74.5M$75.7M
Operating expenses$555.3M$501.9M$527.2M$449.2M$344.4M$272.9M$239.9M$175.5M$90.1M$87.4M
Operating income−$555.3M−$487.3M−$196.7M−$340.7M−$295.8M$62.7M−$213.2M−$46.4M−$90.1M−$87.4M
EBITDAderived−$544.2M−$479.5M−$180.0M−$330.4M−$287.2M$71.2M−$205.2M−$39.0M−$87.1M−$86.0M
Net income−$512.5M−$422.8M−$145.2M−$326.0M−$290.6M$71.1M−$197.6M−$36.2M−$88.2M−$86.7M
Basic EPSper diluted share-$2.97-$2.57-$1.06-$2.60-$2.39$0.65-$2.07-$0.39-$5.89-$13.49
Diluted EPSper diluted share-$2.97-$2.57-$1.06-$2.60-$2.39$0.63-$2.07-$0.39-$5.89-$13.49

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys2$39.98M disclosed value
Sells (SEC code S)42$16.79M disclosed value
44 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jan 6, 2026Form 4Schuth Alexander O.COFO and SecretarySellCommon Stock17.2K$16.50$284.1K282.8K
Jan 6, 2026Form 4Watts Ryan J.President and CEOSellCommon Stock35.2K$16.50$580.8K296.8K
Dec 11, 2025Form 4BAKER JULIAN +5DirectorBuy$0.01 Prefunded Warrants · derivative · indirect2.10M$17.49$36.64M26.00M
Dec 11, 2025Form 4BAKER JULIAN +5DirectorBuy$0.01 Prefunded Warrants · derivative · indirect190.5K$17.49$3.33M2.34M
Aug 13, 2025Form 4 · 10b5-1Ho CaroleChief Medical OfficerSellCommon Stock806$14.64$11.8K216.6K